United States

Michael Erman

Merck raised prices five drugs including Keytruda in November

Nov 28 2018

NEW YORK Merck & Co Inc said on Wednesday it raised U.S. prices on five of its drugs earlier in November by between 1.5 percent and 6 percent, including its top-selling cancer treatment Keytruda.

Pfizer to raise U.S. drug prices in January after previously backing down

Nov 16 2018

NEW YORK Pfizer Inc said on Friday that it plans to hike U.S. prices on 41 of its medicines in January, after walking back its previous planned price increases this summer under pressure from President Donald Trump.

Walmart, Home Depot adopt health insurer tactic in drug copay battle

Nov 13 2018

NEW YORK Walmart and Home Depot , two of the top 10 U.S. employers, have embraced a health insurance strategy that punishes drugmakers for using discount cards to keep patients from switching or stopping their medications.

Lilly says diabetes drug Trulicity reduces heart risks in trial

Nov 05 2018

Eli Lilly and Co said on Monday that its top-selling diabetes drug Trulicity significantly reduced the risk of heart attack, stroke and heart-related death in a broad range of people with type 2 diabetes, according to results of a large clinical trial.

AbbVie sees hit to Humira sales from European competition

Nov 02 2018

U.S. drugmaker AbbVie Inc on Friday lowered its forecast for overseas sales of its top-selling medicine, Humira, due to larger-than-expected pricing cuts because of new competition in Europe.

Pfizer revenue worse than expected as generic competition weighs

Oct 30 2018

Pfizer Inc on Tuesday reported worse-than-expected third quarter revenue and lowered the top end of its full-year sales forecast as generic competition and drug pricing pressure in the United States hurt its older drugs business.

Novartis, Pfizer join forces on potentially lucrative fatty liver disease

Oct 29 2018

ZURICH/NEW YORK Novartis AG and Pfizer Inc are teaming up to develop treatments for a liver disease many drug companies believe will become a hugely lucrative market, as it is tied to the obesity and diabetes epidemics.

Trump seeks to base Medicare drug prices on lower overseas rates

Oct 25 2018

WASHINGTON/NEW YORK U.S. President Donald Trump, taking aim at "global freeloading," said on Thursday his administration would seek to lower prescription drug prices by basing what the government's Medicare program pays for some medications on the lower prices paid in other countries.

World News